Mobia Medical is pursuing an IPO to fund commercialization of its FDA-approved Vivistim neurostimulation device for stroke ...

NEW YORK, July 31, 2024 /PRNewswire/ -- The global neurostimulation devices market size is estimated to grow by USD 6.26 billion from 2023-2027, according to Technavio. The market is estimated to grow ...

For many people living with multiple sclerosis (MS), walking can become one of the most challenging daily tasks. As many as 3 in 4 people with MS have gait issues caused by factors like loss of muscle ...

Evening, I'm Carol Clark, and news for your health diabetic neuropathy. Nearly half of those who deal with diabetes also deal with the problem of nerve pain, numbness, tingling, or burning in their ...

DUBLIN--(BUSINESS WIRE)--Mainstay Medical Holdings plc (the “Company”) today announced the limited commercial launch in the U.S. of ReActiv8, its implantable Restorative Neurostimulation™ system to ...

Neuroscience company Panaxium Research Inc. is developing personalized neurostimulation therapies to restore lost motor function following stroke and traumatic brain injury. Its platform integrates ...

Medtronic is offering a peek into its ongoing, at-home trial of people with Parkinson’s disease being treated with adaptive deep brain stimulation, a technology that’s currently under review at the ...

Medtronic has launched a study of its neurostimulation therapy device to optimal medical management along for the treatment of failed back surgery syndrome and low back pain. The study is a ...

Sometimes psychologists keep seeing the same work pop up over and over again over the course of their career, and they think, "Man, that person really has their finger on the pulse of what matters!" ...

Co announces the FDA has granted pre-market approval to its new Specify 5-6-5 surgical lead for neurostimulation therapy, a safe and effective treatment for chronic pain that uses the company's ...